Patients with IBD have increased platelet counts, factor V and VIII levels, and fibrinogen levels and decreased antithrombin III levels, all of which can increase the risk of thrombosis [2, 20–26]. This evidence concerns the gene SERPINC1 and inflammatory bowel disease.